Favorite Annette F's Form 4 filing
West Pharmaceutical Services Inc (WST) · filed Sep 15, 2026
- Accession no.
- 0000105770-26-000110
- Filed
- Sep 15, 2026, 4:37 PM ET
- Trade date
- Sep 11-15, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.67M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Favorite Annette FCIK 0001654975 | Officer (Sr. VP & Chief HR Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | MOption exerciseAcquired | +2,500 | $89.64 | +$224,100 | 24,317.8098 | Direct | |
| Sep 11, 2026 | Common Stock | SSaleDisposed | −2,500 | $345.00 | −$862,500 | 21,817.8098 | Direct | |
| Sep 14, 2026 | Common Stock | MOption exerciseAcquired | +2,500 | $89.64 | +$224,100 | 24,317.8098 | Direct | |
| Sep 14, 2026 | Common Stock | SSaleDisposed | −2,500 | $355.00 | −$887,500 | 21,817.8098 | Direct | |
| Sep 15, 2026 | Common Stock | MOption exerciseAcquired | +2,524 | $89.64 | +$226,251.36 | 24,341.8098 | Direct | |
| Sep 15, 2026 | Common Stock | SSaleDisposed | −2,524 | $365.00 | −$921,260 | 21,817.8098 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 5,024 | Direct | |
| Sep 14, 2026 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 2,524 | Direct | |
| Sep 15, 2026 | Common Stock | MOption exerciseDisposed | −2,524 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.